Lee Jae Hyuk, Kim Kyuseok, Jo You Hwan, Kim Kyung Su, Lee Christopher C, Kwon Woon Yong, Rhee Joong Eui, Suh Gil Joon, Singer Adam J
Department of Emergency Medicine, Seoul National University College of Medicine, Seoul, Korea.
J Emerg Med. 2009 Nov;37(4):376-82. doi: 10.1016/j.jemermed.2008.07.004. Epub 2008 Dec 20.
Severe hemorrhagic shock often results in cardiac arrest due to vital organ hypoperfusion, especially of the heart. Although fluid resuscitation is the mainstay of management in hemorrhagic shock, treatment of cardiac arrest in association with severe hemorrhagic shock is unclear.
This study was designed to determine the effect of early infusion of norepinephrine on hemodynamics and survival in hemorrhagic shock.
Twelve Sprague-Dawley rats were bled to about 35% of estimated blood volume for 30 min and randomized to one of two groups: the study group received norepinephrine (10 microg/kg/min) in 5% dextrose solution (n = 6); the control group received the same volume of 5% dextrose (n = 6) concurrently with Lactated Ringer's solution. After 30 min of resuscitation, half of the shed blood was transfused in both groups. Time to cardiac arrest and mean arterial pressure (MAP) were compared between the two groups.
MAP during the resuscitation period was higher in the norepinephrine group than in the control group. Five of 6 rats in the norepinephrine group but none of the control group survived until the transfusion period (83.3% vs. 0.0%, respectively; p = 0.003). Median time to cardiac arrest was significantly longer in the norepinephrine group (67.0 min, interquartile range [IQR] 60.0-77.0) than in controls (41.0 min, IQR 40.0-47.0; p = 0.002).
Early use of norepinephrine in a rat model of hemorrhagic shock increased mean arterial pressure during the resuscitation period and delayed the onset of cardiac arrest.
严重失血性休克常因重要器官灌注不足,尤其是心脏灌注不足而导致心脏骤停。尽管液体复苏是失血性休克治疗的主要手段,但与严重失血性休克相关的心脏骤停的治疗尚不清楚。
本研究旨在确定早期输注去甲肾上腺素对失血性休克血流动力学和生存率的影响。
将12只Sprague-Dawley大鼠放血至估计血容量的约35%,持续30分钟,然后随机分为两组:研究组接受含5%葡萄糖溶液的去甲肾上腺素(10微克/千克/分钟)(n = 6);对照组接受相同体积的5%葡萄糖(n = 6)并同时输注乳酸林格氏液。复苏30分钟后,两组均输注一半的失血。比较两组的心脏骤停时间和平均动脉压(MAP)。
去甲肾上腺素组复苏期间的MAP高于对照组。去甲肾上腺素组6只大鼠中有5只存活至输血期,而对照组无一存活(分别为83.3%对0.0%;p = 0.003)。去甲肾上腺素组心脏骤停的中位时间(67.0分钟,四分位间距[IQR] 60.0 - 77.0)显著长于对照组(41.0分钟,IQR 40.0 - 47.0;p = 0.002)。
在失血性休克大鼠模型中早期使用去甲肾上腺素可提高复苏期间的平均动脉压并延迟心脏骤停的发生。